Across TCGA patient cohorts, USP9YP22 RNA expression is significantly associated with the go_rna of many other GO terms, with 3,396 significant associations in total. STAD shows the largest number of these associations.

The most reproducible USP9YP22-associated GO terms across cancer lineages are Protein K63-linked deubiquitination, Regulation of peptidyl-serine phosphorylation, and Antigen receptor-mediated signaling pathway. Each is linked with USP9YP22 in more than 2 cancer types. Because this analysis shows association rather than direction, both USP9YP22-to-partner and partner-to-USP9YP22 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (USP9YP22→partner) and Y-score (partner→USP9YP22) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
STAD	Protein K63-linked deubiquitination →	+0.112	+0.034	<.001	.003	3	3
STAD	Regulation of peptidyl-serine phosphorylation →	+0.105	+0.050	<.001	.002	3	3
STAD	Antigen receptor-mediated signaling pathway →	+0.141	+0.058	<.001	.004	3	3
STAD	Regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator →	+0.162	+0.032	<.001	.005	3	2
STAD	Positive regulation of CD4-positive, alpha-beta T cell activation →	+0.125	+0.063	<.001	.002	3	2
STAD	Regulation of T-helper 2 cell differentiation →	+0.106	+0.056	<.001	.008	3	2

Each partner links to its Q-omics profile. Showing the 6 strongest of 3,396 associations by consensus.

Exploration

USP9YP22 survival (RNA) · tumor vs normal (RNA) · all USP9YP22 data types